Drug ID: | NPD8149 |
Drug Name: | XR-9051 |
Molecular Formula: | C39H38N4O5 |
Canonical SMILES: | COc1cc2CN(CCc3ccc(cc3)NC(=O)c3cccc(c3)/C=c/3 c(O)/c(=C/c4ccccc4)/n(c3=O)C)CCc2cc1OC |
Standard InCHI: | InChI=1S/C39H38N4O5/c1-42-34(22-27-8-5-4-6-9-27)38(45)41-33(39(42)46)21-28-10-7-11-30(20-28)37(44)40-32-14-12-26(13-15-32)16-18-43-19-17-29-23-35(47-2)36(48-3)24-31(29)25-43/h4-15,20-24H,16-19,25H2,1-3H3,(H,40,44)(H,41,45)/b33-21-,34-22- |
Standard InCHIKey: | RTIZZWMBGKGLFO-YWQXDYITSA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB006881 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 642.28 |
ALogP | -0.7513 |
MLogP | 4.76 |
XLogP | 8.998 |
HDA | 7 |
HBD | 2 |
Rotatable Bonds | 14 |
TPSA | 103.7 |
RO5 Violation | 1 |